Reactions Weekly

, Volume 1658, Issue 1, pp 184–184 | Cite as

Erlotinib

Acquired drug resistance following EGFR mutation: case report
Case report
  • 21 Downloads

Reference

  1. Stratmann J, et al. ROS1 translocation as a bystander mutation in T790M EGFR mutated NSCLC. Journal of Thoracic Oncology 12 (Suppl. 1): S1260 abstr. 02b-110, No. 1, Jan 2017. Available from: URL: http://www.sciencedirect.com/science/article/pii/S1556086416330192 - Germany

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations